Mechanisms of disease: Genetics of Paget's disease of bone and related disorders

Nature Clinical Practice Rheumatology

Volumn 2, Issue 5, 2006, Pages 270-277

  Daroszewska, Anna ^a   Ralston, Stuart H ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bone; Osteoclast; Paget's disease; SQSTM1; Ubiquitin

Indexed keywords

ADENOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEASOME; PROTEIN P62; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 11A; TUMOR NECROSIS FACTOR RECEPTOR 11B; UBIQUITIN; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

AGING; AMINO ACID SUBSTITUTION; BONE MALFORMATION; BONE METABOLISM; BONE TURNOVER; CLINICAL FEATURE; DISEASE SEVERITY; FAMILIAL DISEASE; FRONTOTEMPORAL DEMENTIA; GENE INSERTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HETEROZYGOSITY LOSS; HUMAN; INCIDENCE; INCLUSION BODY MYOSITIS; LINKAGE ANALYSIS; MISSENSE MUTATION; MORBIDITY; MORTALITY; ONSET AGE; OSTEOCLAST; OSTEOLYSIS; OSTEOSARCOMA; PAGET BONE DISEASE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

CARRIER PROTEINS; CELL CYCLE PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; LOSS OF HETEROZYGOSITY; MEMBRANE GLYCOPROTEINS; MYOSITIS, INCLUSION BODY; NF-KAPPA B; OSTEITIS DEFORMANS; OSTEOLYSIS; OSTEOPROTEGERIN; POLYMORPHISM, GENETIC; PROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 33646447842     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0172     Document Type: Review

References (60)

1. Meunier PJ et al. (1980) Bone histomorphometry in Paget's disease. Quantitative and dynamic analysis of pagetic and nonpagetic bone tissue. Arthritis Rheum 23: 1095-1103
2. Friedrichs WE et al. (2002) The pro and con of measles virus in Paget's disease: Pro. J Bone Miner Res 17: 2293
3. Rima BK (2002) The pro and con of measles virus in Paget's disease: Con. J Bone Miner Res 17: 2290-2292
4. Cooper C et al. (1999) The epidemiology of Paget's disease in Britain: is the prevalence decreasing? J Bone Miner Res 14: 192-197
5. Altman RD et al. (2000) Prevalence of pelvic Paget's disease of bone in the United States. J Bone Miner Res 15: 461-465
6. van Staa TP et al. (2002) Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 17: 465-471
7. Rogers J et al. (2002) Paget's disease in an archeological population. J Bone Miner Res 17: 1127-1134
8. Cundy HR et al. (2004) Paget's disease of bone in New Zealand: Continued decline in disease severity. Calcif Tissue Int 75: 358-364
9. Tiegs RD et al. (2000) Long-term trends in the incidence of Paget's disease of bone. Bone 27: 423-427
10. Gennari L et al. (2005) Prevalence of Paget's disease of bone in Italy. J Bone Miner Res 20: 1845-1850
11. Siris ES (1994) Epidemiological aspects of Paget's disease: Family history and relationship to other medical conditions. Semin Arthritis Rheum 23: 222-225
12. Solomon LR (1979) Billiard-player's fingers: An unusual case of Paget's disease of bone. Br Med J 1: 931
13. Montagu MFA (1949) Paget's disease (osteitis deformans) and hereditary. Am J Hum Genet 1: 94-95
14. Hocking L et al. (2000) Familial Paget's disease of bone: Patterns of inheritance and frequency of linkage to chromosome 18q. Bone 26: 577-580
15. Morales-Piga AA et al. (1995) Frequency and characteristics of familial aggregation of Paget's disease of bone. J Bone Miner Res 10: 663-670
16. Siris ES et al. (1991) Familial aggregation of Paget's disease of bone. J Bone Miner Res 6: 495-500
17. Sofaer JA et al. (1983) A family study of Paget's disease of bone. J Epidemiol Community Health 37: 226-231
18. Eekhoff EW et al. (2004) Familial Paget's disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 50: 1650-1654
19. Hocking L et al. (2002). Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 11: 2735-2739
20. Barker DJ (1984) The epidemiology of Paget's disease of bone. Br Med Bull 40: 396-400
21. Osterberg PH et al. (1988) Familial expansile osteolysis. A new dysplasia. J Bone Joint Surg Br 70: 255-260
22. Nakatsuka K (2003) Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 18: 1381-1385
23. Whyte MP and Hughes AE (2002) Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 17: 26-29
24. Whyte MP et al. (2002) Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med 347: 175-184
25. Kovach MJ et al. (2001) Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 74: 458-475
26. Tilyard MW et al. (1982) A probable linkage between familial Paget's disease and the HLA loci. Aust NZ J Med 12: 498-500
27. Hughes AE et al. (1994) Genetic linkage of familial expansile osteolysis to chromosome 18q. Hum Mol Genet 3: 359-361
28. Laurin N et al. (2001) Paget disease of bone: Mapping of two loci at 5q35-qter and 5q31. Am J Hum Genet 69: 528-543
29. Hocking LJ et al. (2001) Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2836, 10p13, and 5q35. Am J Hum Genet 69: 1055-1061
30. Good DA et al. (2001) Linkage of Paget disease of bone to a novel region on human chromosome 18q23. Am J Hum Genet 70: 517-525
31. Cundy T et al. (2002) A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet 11: 2119-2127
32. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289: 1504-1508
33. Hughes AE et al. (2000) Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 24: 45-48
34. Palenzuela L et al. (2002) Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. J Med Genet 39: E67
35. Johnson- Pais TL et al. (2003) Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J Bone Miner Res 18: 376-380
36. Sparks AB et al. (2001) Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarooma. Calcif Tissue Int 68: 151-155
37. Wuyts W et al. (2001) Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 28: 104-107
38. Nellissery MJ et al. (1998) Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. Am J Hum Genet 63: 817-824
39. B Chong (2003) Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. J Bone Miner Res 18: 2095-2104
40. Hocking LJ et al. (2004) Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: Genotype phenotype correlation, functional analysis and structural consequences. J Bone Miner Res 19: 1122-1127
41. Good DA et al. (2004) Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone 35: 277-282
42. Johnson-Pais TL et al. (2003) Three novel mutations in SQSTM1 identified in familial Paget's disease of bone. J Bone Miner Res 18: 1748-1753
43. Beyens G et al. (2004) Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease. Calcif Tissue Int 75: 144-152
44. Ciani B et al. (2003) Structure of the UBA domain of p62 (SQSTM1) and implications for mutations which cause Paget's disease of bone. J Biol Chem 278: 37409-37412
45. Cavey JR et al. (2005) Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutations. J Bone Miner Res 20: 619-624
46. Layfield R and Hocking LJ (2004) SQSTM1 and Paget's disease of bone. Calcif Tissue Int 75: 347-357
47. Chen ZJ (2005) Ubiquitin signalling in the NFkB pathway. Nat Cell Biol7: 758-766
48. Laurin N etal. (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70: 1582-1588
49. Lucas GJ et al. (2005) Ubiquitin-associated domain mutations of SQSTM1 in Paget's disease of bone: Evidence for a founder effect in patients of British descent. J. Bone Miner Res 20: 227-231
50. Duran A et al. (2004) The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell 6: 303-309
51. Daroszewska A et al. (2004) Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin. J Bone Miner Res 19: 1506-1511
52. Wang Q et al. (2004) Molecular perspectives on p97-VCP: Progress in understanding its structure and diverse biological functions. J Struct Biol 146: 44-57
53. Watts GD et al. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36: 377-381
54. Dai RM et al. (1998) Involvement of valosin-containing protein, an ATPase co-purified with IκBα and 26S proteasome, in ubiquitin-proteasome-mediated degradation of IκBα. J Biol Chem 273: 3562-3573
55. Lucas GJA et al. (2006) Evaluation of the role of valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Bone 38: 280-285
56. Langston AL and Ralston SH (2004) Management of Paget's disease of bone. Rheumatology (Oxford) 43: 955-959
57. Pei Y (2001) A 'two-hit' model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med 7: 151-156
58. Guise TA and Mundy GR (1998) Cancer and bone. Endocr Rev 19: 18-54
59. Cody JD et al. (1997) Genetic linkage of Paget disease of the bone to chromosome 18q. Am J Hum Genet 61: 1117-1122
60. Good DA et al. (2004) Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone 35: 277-282